Analyst Ratings for Aquestive Therapeutics (AQST)
AQST Rating Summary
AQST Price Target Summary
- Highest: $26.00 (Wedbush)
- Lowest: $5.00 (H.C. Wainwright)
- Average: $12.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$12.50 (+622.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/7/2021 | RBC Capital | Daniel Busb | New Coverage | Outperform (N/A) |
7.00 (N/A) |
5.21 (1.73) |
-66.79% | Details |
| 4/22/2019 | H.C. Wainwright » Updated 6/21/2022 |
Raghuram Selvaraju | New Coverage | Buy (N/A) |
5.00 (8.00) |
6.29 (1.73) |
-72.5% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
